We investigated the role of viridans group streptococci in the prevention of colonization with methicillinresistant Staphylococcus aureus (MRSA) in neonatal intensive care units. During a 26-month period at a children's hospital, 207 (49.9%) of 415 newborns were colonized with MRSA by the time of discharge. Two groups of newborns with matching durations of hospitalization were compared with regard to the prevalence of future colonization with MRSA: group 1 (103 patients) did not acquire colonization with viridans group streptococci and group 2 (63 patients) did acquire colonization with viridans group streptococci at birth or by 1 to 2 weeks (age, р11 days). The rate of colonization among patients in group 2 (9.5%) was significantly lower than that among patients in group 1 (44.7%;
, only a few of these investigations have been reported in recent years [8, 9] . Recently, we also studied this problem and showed through experiments a similar phenomenon [10] : Corynebacterium species, one of the normal bacterial flora, eliminated MRSA colonization in adult nasal cavities. These results suggested that normal flora play a role in the in prevention of MRSA colonization in newborns. However, during the first several hours or days after birth, newborns in NICUs have no detectable amount of normal flora in their nasal and oral cavities [11, 12] . Moreover, rigorous protection of newborns from contact with pathogens and frequent use of antibiotics possibly delay not only colonization with pathogenic bacteria but also colonization with normal flora [13] .
At Nagano Children's Hospital (Toyoshina, Japan), despite an extensive effort to prevent MRSA colonization, about one-half of inpatients in the NICU were colonized consistently with MRSA during a 26-month Figure 1 . Rate of bacterial colonization of oral cavities in newborn inpatients at a neonatal intensive care unit in Japan. The rate of daily bacterial colonization was calculated as follows: the number of bacterial isolations (determined on the basis of the assumption that bacterial colonization continued for several days) was divided by the actual number of inpatients each day. Ϫ/Ϫ, Newborns without colonization with either viridans group streptococci or methicillin-resistant Staphylococcus aureus (MRSA); ϩ/Ϫ, newborns with colonization with viridans group streptococci but without MRSA colonization; Ϫ/ϩ, newborns without colonization with viridans group streptococci but with MRSA colonization; ϩ/ϩ, newborns with colonization with both viridans group streptococci and MRSA.
period. During this time, the other half of the inpatients (those without MRSA colonization) were at serious risk of MRSA colonization, and at the same time, colonization with normal flora was also being prevented by means of rigorous infection control measures. After a certain period of hospitalization, although the situation was risky, many inpatients remained free of colonization with MRSA as well as normal flora. However, the oral cavities of some inpatients without MRSA colonization were colonized with viridans group streptococci in the days soon after birth.
When organisms in a particular ecological niche of the body are studied in laboratory models, the one that reaches the niche first will generally prevail [14] . Moreover, studies have reported that viridans group streptococci inhibit the growth of S. aureus [7, 15] .
In the present study, we analyzed whether former bacterial occupants (e.g., viridans group streptococci) of oral cavities in newborns inhibit later colonization with MRSA.
PATIENTS, MATERIALS, AND METHODS
Background characteristics of the NICU. Nagano Children's Hospital was opened by the Nagano Prefecture Government in May 1992; there are 1150 admissions per year, and all newborns are born in other hospitals and brought to Nagano Children's Hospital by ambulance with a doctor and nurses from the hospital present. During this study, there were 26 bassinets or incubators in the NICU, and the average occupancy rate was 83.1%. The NICU contains 207 m 2 of floor space (7.9 m 2 per newborn), and it is divided into 2 areas: an intensive care area and an intermediate care area. Although this floor space usually meets the American Academy of Pediatrics' standard of 7.4 m 2 per incubator for intensive care [2] , there is sometimes less room than is recommended.
The staff includes 8 doctors and 40 nurses. Routine infection control measures include the following: an initial 3-minute scrub with either povidone-iodine or 2% chlorhexidine at entry to the NICU, hand washing with 2% chlorhexidine between contacts with newborns, gown wearing, changing of shoes, and regular bacterial surveillance of newborns, staff, and environment. MRSA colonization of nasal cavities in infants was eliminated by means of administration of methylrosanilinium chloride ointment [16] (before September 1996) or mupirocin [17] (during and after September 1996). Only infants with nasal colonization who were not intubated were treated with these antimicrobial agents. Surveillance methods. Since the opening of Nagano Children's Hospital, we have been continuously surveying nosocomial infections, including those due to MRSA. Prospective surveillance cultures for all newborns were first performed at the time of admission (when the newborn is !24 h of age), every subsequent Monday during each patient's entire hospitalization, and at 1 day before discharge. According to clinical requirements, cultures were occasionally performed between the prospective cultures, and the results were also used for epidemiological analysis. In this study, test results for day 11 and intermediate days between tests had crucial meanings, but bacteriologic tests were not always performed on these days. We performed all calculations, unless otherwise indicated, on the basis of the assumption that similar bacterial colonization had continued for several days. At the time of admission, specimens of feces and of oral and nasal cavities were obtained for culture for every newborn, and cultures of specimens from oral and nasal cavities were done on Monday as part of routine surveillance. Samples were collected by using wet (0.85% NaCl) cotton swabs, and the swabs were transported immediately to the bacteriology laboratory in modified Amies transport medium with charcoal (Seedswab number 2; Eiken Kizai). On occasion, specimens of breast milk, sputum from bronchial aspiration, and umbilical exudates were also tested.
Microbiological testing. All swabs were inoculated onto plates with 5% sheep blood agar, chocolate agar, modified Drigarsky agar, and OPA Staphylococcus agar (all plates were purchased from Becton Dickinson), and the plates were incubated for 24 h at 37ЊC in 5% CO 2 in air. Bacterial identification and antibiotic susceptibility testing were performed as described elsewhere [18, 19] . MRSA was defined as S. aureus for which the MIC of oxacillin was 14 mg/mL.
Statistical analysis.
Group data are expressed as , and differences between groups were analyzed by means ‫ע‬ SDs use of the paired Student's t test or x 2 test.
RESULTS

Bacterial colonization of nasal and oral cavities in newborns.
During the study period, cultures of specimens from 415 newborns in the NICU at Nagano Children's Hospital were performed. Samples obtained included the following: 3056 nasal cavity specimens, 3020 oral cavity specimens, 1245 sputum specimens from bronchial aspiration, 973 feces specimens, 369 breast milk specimens, 112 umbilical exudates, and 934 other specimens. Approximately 68% of cultures of specimens from nasal and oral cavities were performed at admission or every Monday as a routine surveillance test, but 32% were done on another day of the week. At admission, viridans group streptococci, coagulase-negative Staphylococcus (CNS; including Staphylococcus epidermidis) and group B Streptococcus were isolated from a few newborns, but 97.6% of cultures of nasal cavity specimens and 97.4% of cultures of throat specimens yielded no such isolates. Thereafter, the prevalence of colonization with CNS in the nares and oral cavities began to increase, and on the seventh day, CNS was isolated from almost all newborns (91%). Daily rates of bacterial colonization or absence of colonization/isolation are shown in figure 1. The number of bacterial isolations or negative isolations (including eradication by antibacterial agents) was divided by the actual number of inpatients (discharged inpatients were not included; 73% of the newborns were discharged within 40 days) on each day.
The bacteria (with the exception of CNS) that were most frequently isolated from the oral and nasal cavities during the first several days of hospitalization were viridans group streptococci (newborns with colonization with viridans group streptococci without MRSA colonization), and the rate of isolation of viridans group streptococci was slightly higher than that of MRSA colonization (newborns without colonization with viridans group streptococci but with MRSA colonization). The rate of colonization with MRSA gradually increased and exceeded the rate of colonization with viridans group streptococci of the oral cavities on or after day 11. However, nasal application of methylrosanilinium chloride or mupirocin reduced the increase in the rate of colonization with MRSA, which finally reached a plateau at ∼60% (newborns without colonization with viridans group streptococci but with MRSA colonization).
In the first half of the study, methylrosanilinium chloride was applied to the nares of 78 newborns with MRSA colonization (mean duration of , days) hospitalization ‫ע‬ SD 85 ‫ע‬ 54 3 times per day for a mean duration (‫ע‬SD) of days, 19 ‫ע‬ 13 and MRSA disappeared from the nares and oral cavities of 38 infants (eradication rate, 48.7%). The absence of colonization continued until discharge (mean duration, 46 days). However, in 7 infants, disappearance of colonization was detected only in the final surveillance test, which was performed on the day before discharge. In the latter half of the study period, mupirocin was applied to the nares of 37 infants (mean duration of , days) 2 times per day for 5 days. hospitalization ‫ע‬ SD 46 ‫ע‬ 63 MRSA disappeared from 27 newborns (eradication rate, 72.9%), and the absence of MRSA persisted for a mean duration (‫ע‬SD) of days until the time of discharge. However, 7 ‫ע‬ 12 in 12 infants, the disappearance of colonization was only detected in the final surveillance test. The shorter follow-up of eradication associated with mupirocin, as compared with that associated with methylrosanilinium chloride, was due to delayed application of the agent.
To avoid establishing a resistant strain, we strictly minimized the use of mupirocin. Infants with intubation or comparatively mild disease status who were expected to be discharged within 2-3 weeks of admission did not receive mupirocin treatment. Ninety-two infants with MRSA colonization did not receive treatment with either mupirocin or methylrosanilinium chloride. If the first application of mupirocin failed, it was not applied again. We could not confirm eradication, because further surveillance testing after discharge was not performed.
Because long-term hospitalization may increase the opportunity for contact with viridans group streptococci as well as MRSA, a low incidence of colonization with both viridans group streptococci and MRSA was observed. The number of newborns without colonization with both viridans group streptococci and MRSA gradually decreased as they acquired colonization with either MRSA or viridans group streptococci, although approximately one-half of them did not acquire colonization with either type of bacteria on or after day 11 (table  1) . Colonization with viridans group streptococci and MRSA colonization of nasal or oral cavities in infants whose duration of hospitalization was !11 days (104 of 415; mupirocin was applied to the nares of one of them on day 5, but this treatment failed to eradicate MRSA) or у11 days (311 of 415; methylrosanilinium chloride or mupirocin was applied to the nares of 4 newborns, but there was no success in the eradication of MRSA on or after day 11) are described in Monthly rate of colonization with MRSA in the NICU and the effect of long-term hospitalization. Despite great efforts, the spread of MRSA has not been controlled since the time immediately after the opening of the hospital, and the colonization rate has remained very high. During the 26-month study period (from April 1995 through May 1997), the average monthly rate of MRSA colonization of the nares and oral cavities was as high as 46.5%, and 49.9% (207) of 415 newborn inpatients were colonized until the time of their discharge. Long-term hospitalization was one of the risk factors of MRSA colonization in the NICU. The rate of colonization with MRSA among newborns who were hospitalized for !11 days was comparatively low (17.3%), but among newborns who were hospitalized for 161 days, the rate was 190%. When the duration of hospitalization was 143 days, the MRSA colonization rate increased rapidly, and the number of newborns who were discharged without MRSA colonization (or history of MRSA colonization) decreased significantly ( figure 2A ). When the duration of hospitalization was у43 days, a negative correlation between duration of hospitalization and the number of newborns discharged without MRSA colonization (or history of MRSA colonization) became more significant (figure 2B). To reduce influences on the risk due to long-term hospitalization, 201 inpatients whose duration of hospitalization was 11-40 days were chosen for further study.
Risk factors for MRSA colonization other than long-term hospitalization. A total of 103 of 201 newborns without colonization with both MRSA and viridans group streptococci on or after day 11 (designated as group 1) were subdivided into 2 groups: 46 who acquired MRSA colonization and 57 who did not acquire MRSA colonization. In a similar fashion, 63 hospitalization duration-matched newborn inpatients who had colonization with viridans group streptococci but not MRSA colonization on or after day 11 (designated as group 2) were subdivided into 2 groups: 6 who acquired MRSA colonization and 57 who did not acquire MRSA colonization. The clinical characteristics of these subgroups of patients were compared between the 2 groups (table 2) . Birth weight and other characteristics, even antibiotic use, did not significantly differ between the 2 groups. In fact, no significant difference in characteristics was observed between the 2 groups. Therefore, MRSA colonization of the nares and oral cavities did not seem to depend on any special characteristics of the newborns, and none of these characteristics became risk factors for MRSA colonization.
Interference in MRSA colonization mediated by viridans group streptococci. We hypothesized that colonization with viridans group streptococci counteracted MRSA colonization. To prove this working hypothesis, the prevalence of MRSA colonization in group 1 was compared with that in group 2. Cumulative rates of MRSA colonization among both groups are shown in figure 3 . The rate of MRSA colonization was much lower among the 63 group 2 inpatients (6 [9.5%] of 63]) than among the 103 group 1 inpatients (46 [44.7%] of 103;
). None of the infants with MRSA colonization in group P ! .001 2 were infected with MRSA, while 6 infants with MRSA colonization in group 1 were infected with MRSA (skin infection in 2 infants; omphalitis, in 1; otitis externa, in 1; and blood culture-proven sepsis, in 2). Characteristics of the 2 groups of patients are compared in table 3. No significant difference in the clinical characteristics was observed with the exception of 3 characteristics: incidences of abdominal delivery, intubation, and respiratory distress syndrome were significantly higher for group 1 inpatients than for group 2 inpatients. However, as we have shown above, these characteristics did not lead to MRSA colonization directly when colonization with viridans group streptococci was considered as a criterion for study subjects. Nevertheless, abdominal delivery and intubation are probable risk factors for MRSA colonization, because they may be related to colonization with viridans group streptococci.
The incidence of respiratory distress syndrome was too low to affect colonization with MRSA. Antibiotics were administered to both group 1 inpatients (87%) and group 2 inpatients (82%) before day 11 (low-birth-weight newborns with suspected maternal infection and newborns who had positive signs of infection or who had undergone surgery were treated with antibiotics, such as ampicillin, cefotaxime, cefazolin, piperacillin, and gentamicin), and 82% of the patients in group 1 and 75% of those in group 2 received antibiotic therapy for 
DISCUSSION
Uncontrollable spreading of MRSA in newborns in NICUs has been largely attributed to environmental risk factors [2, 20, 21] . Certainly, overcrowding and understaffing are the overriding conditions that predispose NICUs to the long-standing problem of endemic infection with MRSA. However, factors that involve the newborns themselves also seem to play an important role with regard to MRSA colonization. Normal flora has the ability to inhibit colonization with pathogenic bacteria in older people [5] [6] [7] . However, few investigators have studied whether normal flora really inhibits MRSA colonization in newborns. The present study shows the role of viridans group streptococci in the prevention of MRSA colonization of oral and nasal cavities in newborns.
Colonization with MRSA is achieved through a number of continuous processes: arrival of bacteria from other sources to the appropriate place in the newborn, specific attachment of bacteria to molecules on epithelial cells, and proliferation of bacteria in that place [22] . Interruption of the continuous flow of the colonization process at any point is likely to inhibit colonization with MRSA. Current methods of prevention of colonization, therefore, focus either on preventing patient-pathogen contact [21] [22] [23] or on preventing growth of colonizing microorganisms [16, 17] . However, none of the individual conventional control measures concerning these processes (such as an emphasis on hand washing, gown and glove wearing, isolation of colonized and infected infants, and even administration of antibiotics) succeeded in controlling the spread of MRSA in an NICU [20] . Recently, mupirocin-resistant S. aureus [24] [25] [26] and vancomycin-resistant S. aureus [3] have been reported. Only when the usual control measures were performed in combination with a reduction in overcrowding and an increase in staffing was control of the spread of MRSA achieved, albeit only barely [2] . Therefore, characteristics of newborns in NICUs, such as low birth weight, presence of diseases, and lack of normal bacterial flora, likely contribute to the difficulty experienced in attempting to control the spread of MRSA.
Low-birth-weight infants certainly have a higher risk of infection than do normal-weight newborns [27, 28] , although this risk does not always mean, as we have indicated in the present report, that MRSA colonization occurs more frequently in low-birth-weight infants. On a similar note, none of the special diseases (such as patent ductus arteriosus, sepsis, and asphyxia neonatorum) interfere with the rate of MRSA colonization. Our data indicate that colonization with MRSA of a newborn's mucosa with no former bacterial occupants depends only on accidental contact with the bacteria and that, once contact is achieved, no newborn (irrespective of disease status) can avoid colonization. This phenomenon supports the conclusions of the study by Wickman [14] , which showed that the bacterium that reaches the niche first will generate and prevail.
The mother's obstetric canal may play an important role in the formation of normal flora in newborns. Corynebacteria and CNS are usually isolated from a newborn's skin within a few hours of birth and, simultaneously, from the vagina of the mother [12] . Bacteroides fragilis, a fecal flora, can be isolated from newborns who are vaginally delivered within 48 h of birth, but few of these bacteria are isolated from newborns who are abdominally delivered [11] . On a similar note, in our study, 82.6% of the newborn inpatients who were colonized with viridans group streptococci before the 11th day of life were vaginally delivered. Therefore, the obstetric canal and the surrounding body surfaces are major sources of normal bacterial flora for newborns. Nevertheless, the oral cavities of 64% of our newborns who were delivered vaginally remained free of colonization with viridans group streptococci on or after day 11. Moreover, according to our data and the findings of other investigators [29] , antibiotic administration never delays colonization with normal flora, even if the normal bacterial flora is susceptible to the antibiotic administered. Therefore, environmental factors also seem to be important in the formation of normal flora in newborns. However, rigorous infection control measures performed in NICUs effectively suppress the opportunity for staff and mothers or fathers to spread normal flora to newborns. This delay in colonization probably increases the rate of MRSA colonization among newborns delivered by means of cesarean section.
The mechanisms of interference mediated by oral bacteria in this report are not clear, although many investigators have reported that viridans group streptococci produce substances with bacteriocin-like activity, including H 2 O 2 [7, 11, [29] [30] [31] . In the accompanying article [32] , we report the results of our investigation of the role of H 2 O 2 in preventing MRSA colonization of oral cavities in newborns.
